Skip to content

Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients

Intranasal Dexmedetomidine Versus Midazolam for Premedication in Deep-sedated Pediatric Dental Patients: a Double-blinded, Prospective, Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04509414
Enrollment
100
Registered
2020-08-12
Start date
2020-04-10
Completion date
2022-05-31
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Sedation, Dexmedetomidine

Keywords

deep sedation, pediatric, dexmedetomidine, dental treatment

Brief summary

It is important to choose an appropriate analgesia/sedation technique in pediatric dental treatment. Premedication combined with intravenous anesthesia is often used in deep sedation technique for pediatric dental treatment and it's a routine in most hospitals. Deep sedation has its unique advantages such as avoiding the airway damage with an enhanced recovery. Dexmedetomidine is suitable for intranasal mucosal administration as a premedication drug. It has been proved with several beneficial characteristics in other clinical procedures. This study intends to further explore the characteristics of nasal dexmedetomidine as premedication in pediatric oral treatment under deep sedation.

Interventions

DRUGDexmedetomidine

For dexmedetomidine group after ramdomization, an intranasal dose of 2ug/kg dexmedetomidine will be administrated.

DRUGMidazolam

For midazolam group after ramdomization, an intranasal dose of 0.2mg/kg midazolam will be administrated.

Sponsors

Peking University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

1. children in need of deep sedation for dental treatment aged 3-7 years. 2. anticipated operation time 1-2hours

Exclusion criteria

1. any known medical records with neural or mental disorder 2. any known medical records with severe systemic disorder 3. history of sedation drug administration in recent 1 months 4. any known allergic history of dexmedetomidine, midazolam or propofol 5. morbid obesity 6. history of OSAHS or acute respiratory infection in 2 weeks 7. other conditions which the attending considers to be unfit for the trial

Design outcomes

Primary

MeasureTime frameDescription
venipuncture acceptanceDay 0acceptance while starting the IV line, at most 2 tries

Secondary

MeasureTime frameDescription
Observer's Assessment of Alertness/Sedation(MOAA/S) ScoreDay 0sedation scoring with MOAA/S scale(from intranasal drug administration till discharge)
remedial mask induction acceptanceDay 0acceptance of the mask induction(for those failed to start the IV before induction)
propofol dosageDay 0the total dosage of propofol used from induction till the end of the clinical treatment
patients' discomfortup to 24 hoursany adverse reaction or discomfort complaints of patients will be recorded, such as sneeze, blocked nose, bitter taste, dizziness, rhinalgia, etc.
hypoxemiaDay 0decreased oxygen saturation up to 90%, and the treatment will also be recorded(if any)
peri-operative blood pressureDay 0peri-operative blood pressure states
post-operative agitationDay 0emergence agitation assessment with Pediatric Anesthesia Emergence Delirium scale(PAED) from the end of dental procedure till discharge
discharge timeDay 0time from the end of dental procedure till discharge
peri-operative heart rateDay 0peri-operative heart rate
times of intra-operative airway assistanceDay 0Any intra-operative airway assistance in need which aims to improve ventilation will be recorded, including jaw lifting, suction, mask ventilation and intubation. Specific type of assistance will also be recorded in detail.
post-operative painDay 0pain assessment with modified children's hospital of eastern Ontario pain score(m-CHEOPS) from the end of dental procedure till discharge

Other

MeasureTime frameDescription
peri-operative satisfactionup to 24 hourssatisfaction of surgeon and parents during the whole clinical treatment and follow-up, they will be asked to give a score from 1 to 10, 10 stands for completely satisfied and 1 stands for not satisfied at all
post-operative condition of the childup to 24 hourscomplications and behavior changes assessed with Post-Hospitalization Behavior Questionnaire(PHBQ)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026